ARCHIVES

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

This article is from The Cancer Letter archive.

Vol. 39 No. 25 | June 21, 2013

Download PDF Visit The Full Archive

Related Articles

Improvements Still Needed To Reduce Chemo Errors

November 25, 2005

OMB Caused The Problem But Did Not Order Transfer Of $20 Million From Centers Program to Grants Poll

April 29, 1983

NCI Payline To Jump To 25th Percentile For A Portion Of Grants, Director Says

April 24, 2009

ASCO Foundation Renamed

February 18, 2011

Grants & Contracts: NCI Workshop Informs Historically Black Institutions About Funding Process

October 10, 1997

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012